Could simple supplements improve lung health in rare disease?
NCT ID NCT06959251
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether taking glycine and magnesium+thiamine supplements for 6 months can reduce lung infections and improve breathing in people with primary ciliary dyskinesia (PCD), a rare lung condition. About 60 participants aged 5 and older will receive either one or both supplements, or a placebo powder. The goal is to see if these safe, low-cost options can ease symptoms and boost quality of life.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY CILIARY DYSKINESIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Instituto Nacional de Enfermedades Respiratorias
RECRUITINGMexico City, 14080, Mexico
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could exercise be a new way to clear lungs in PCD?
- Can better testing unlock the secrets of a rare lung disease?
- Tiny hairs in fallopian tubes may hold key to ectopic pregnancy
- Could a simple saltwater mist make breathing easier for lung patients?
- Rare lung disease study aims to uncover key health markers
- 300-Patient study aims to unlock secrets of rare lung disease